Symposium: Opportunities, Hopes, and Challenges in Translating Visual Restoration from Mouse to Human
Live date was Sep 17th, 2023
Missed the live date? Don't worry!
Register now and view the recording of the presentation.
Striatech celebrates its 5th anniversary with a top-class Symposium on the topic of translating visual restoration from mouse to human. On Sunday, September 17th, the event will take place on site at the Westspitze in Tübingen and also be broadcasted live online.
There will be a moderated panel discussion at the end. Questions can be asked on site, as well as online.
Food and beverages will be provided during breaks at Westspitze for the convenience of our on-site guests.
Professor Eberhart Zrenner: Transmitting Images to the Brain of Blind Patients by Means of Electronic Implants
Miikka Terho, MBA: Personal Experiences of Testing and Using the Retinal Implant
Constance Cepko, PhD: Gene-Agnostic Approaches to Retinal Degeneration
About the speaker
Professor Eberhart Zrenner
Senior Professor of Ophthalmology
Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen
Eberhart Zrenner is Professor of Ophthalmology at the Center for Ophthalmology, University of Tübingen. He has made major contributions to advance basic science, clinical diagnosis and treatment in inherited retinal dystrophies, improving our understanding of disease origin as well as retinal function and dysfunction. He and his team have developed a unique electronic subretinal prosthesis with 1600 pixels, implanted in more than 70 patients and have successfully performed the first gene therapy trial in achromatopsia (CNGA3).
Constance Cepko, PhD
Professor of Genetics and Ophthalmology
Harvard Medical School
Dr. Cepko received her PhD degree from the Massachusetts Institute of Technology, working with Phillip Sharp on adenovirus capsid assembly, and remained at MIT as a postdoctoral fellow in the laboratory of Richard Mulligan, where she was involved in the development of retrovirus-mediated gene transduction. She moved to Harvard Medical School as a faculty member to join the newly formed Department of Genetics in 1985. Her laboratory studies cell fate determination in the retina, using molecular and cellular method, and is using AAV vectors to develop therapies for a wide range of retinal degenerations.
Miikka Terho, MBA
Marketing and Finance Specialist
Pioneer Retina Implant Patient, Finland
Miikka Terho has worked as a lecturer in finance and marketing in various academic institutions. He was founder and, for over 20 years, managing director of a sports management agency until 2012. Since 2008, he has participated as a patient in clinical trials at the University of Tübingen and Retina Implant AG. In his presentation he will talk about personal experiences of testing and using the retinal implant chip developed by Professor Zrenner. He will give insights on how it felt to see something after many years of blindness and eventually face the reality that the science cannot yet restore vision completely.
Sep 17th, 2023
Other Journal Clubs and Webinars
Journal Club: Postsynaptic Neuronal Activity Promotes Retinal Axon Regeneration
Journal Club: Inherited Retinal Dystrophy: Chronic Proinflammatory Signaling Accelerates the Rate of Degeneration
Journal Club: Developing Retinal Gene Therapy for Zellweger Spectrum Disorder (ZSD)
Journal Club: In Vivo Modeling of Immune-mediated Optic Neuropathies
Journal Club: Endothelial Caspase-9 Mediates Inflammatory and Vision Function Changes in Retinal Vascular Injury